Publications by authors named "A Molonia"
Effects of a Dietary Supplement Composed of Baicalin, Bromelain and Escin for Venous Chronic Insufficiency Treatment: Insights from a Retrospective Observational Study.
Pharmaceuticals (Basel)
June 2024
Article Synopsis
- Chronic venous insufficiency (CVI) can increase the risk of cardiovascular events, and its primary treatments are compression stockings and lifestyle changes, potentially supported by natural products like flavonoids.
- This study evaluated the effects of a dietary supplement containing baicalin, bromelain, and escin in CVI patients through a retrospective analysis of medical records.
- Results showed significant improvements in the clinical symptoms of "users" of the supplement compared to "non-users," including reduced pain, inflammation, and overall severity of CVI, along with lower C-reactive Protein levels.
Article Synopsis
- The study aimed to analyze changes in glomerular filtration ratio (GFR) among diabetic patients and identify related risk factors under the care of General Practitioners (GPs).
- Researchers recruited 545 diabetic patients, estimated their GFR based on creatinine values, and used linear regression to determine predictors of eGFR changes.
- Findings revealed that most patients were on glucose-lowering medications, often had prescriptions for nephrotoxic drugs, and highlighted the need for closer monitoring of diabetic patients' kidney health, irrespective of their current GFR levels.
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and in recent years the pharmacological approach has been strongly implemented; in Italy, the prescription of the non-vitamin K oral anticoagulants (NOAC) was also extended to General Practitioners (GPs) since 2020. The aim of the present study was to investigate the GPs prescribing behaviour of NOACs. An observational study was performed by using the computerized medical record of 14 GPs in Sicily: patients affected by AF were selected and stratified according to the prescribed antithrombotic drugs.
View Article and Find Full Text PDFType 2 diabetes mellitus (T2DM) severely increases the probability of developing coronary artery disease (CAD), and diabetic patients with CAD should be considered at very high cardiovascular risk. The complexity of this clinical scenario makes very hard the appropriateness of the pharmacological treatment in the real world. To investigate the implementation of guideline recommendations for the treatment of patients affected by CAD with or without T2DM, a retrospective observational study was carried out between 2018 and 2020, by using the computerized clinical medical record of 10 general practitioners (GPs) including 13,206 subjects.
View Article and Find Full Text PDF